Transferrin receptor-involved HIF-1 signaling pathway in cervical cancer | |
Xiaofeng Xu; Tao Liu; Jun Wu; Yijin Wang; Ying Hong; Huaijun Zhou | |
刊名 | Cancer Gene Therapy |
2019 | |
ISSN号 | 1476-5500 |
URL标识 | 查看原文 |
公开日期 | [db:dc_date_available] |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4602632 |
专题 | 湖南大学 |
作者单位 | 1.000 0004 1800 1685, grid.42839 2.6, Department of Gynecology, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, 210008, Nanjing, China 3.0000 0004 1800 1685, grid.42839 4.6, Department of Gynecology, Nanjing Drum Tower Hospital, Affiliated to Nanjing University Medical School, 210008, Nanjing, China 5.0000 0001 2314 964X, grid.4115 6.37, Medical College, Nanjing University, 210008, Nanjing, China 7.0000 0004 1761 0489, grid.26382 8.b, Medical College, Southeast University, 210008, Nanjing, China |
推荐引用方式 GB/T 7714 | Xiaofeng Xu,Tao Liu,Jun Wu,et al. Transferrin receptor-involved HIF-1 signaling pathway in cervical cancer[J]. Cancer Gene Therapy,2019. |
APA | Xiaofeng Xu,Tao Liu,Jun Wu,Yijin Wang,Ying Hong,&Huaijun Zhou.(2019).Transferrin receptor-involved HIF-1 signaling pathway in cervical cancer.Cancer Gene Therapy. |
MLA | Xiaofeng Xu,et al."Transferrin receptor-involved HIF-1 signaling pathway in cervical cancer".Cancer Gene Therapy (2019). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论